Adverse COVID-19 vaccination effects in Finnish patients with Meniere's disease : a cross-sectional study

Show simple item record

dc.contributor.author Beukes, Eldre W.
dc.contributor.author Manchaiah, Vinaya
dc.contributor.author Pyykko, Nora
dc.contributor.author Pyykko, Ilmari
dc.date.accessioned 2023-06-27T05:51:17Z
dc.date.available 2023-06-27T05:51:17Z
dc.date.issued 2022-08-04
dc.description DATA AVAILABILITY : UNDERLYING DATA : Figshare: COVID 19 vaccine in Ménière’s disease, https://doi.org/10.6084/m9.figshare.19519801. This project contains the following underlying data: - COVID vaccine in MD for repository.xslx (raw data). EXTENDED DATA : Figshare: COVID 19 vaccine in Ménière’s disease, https://doi.org/10.6084/m9.figshare.19519801. This project contains the following extended data: - Finnish_MD COVID Vaccination Questionnaire - English_MD COVID Vaccination Questionnaire - S 1S1 The STROBE Checklist. Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0). en_US
dc.description.abstract BACKGROUND : The association between reporting adverse coronavirus disease 2019 (COVID-19) vaccination effects and those with a history of audiovestibular difficulties is unknown. The aim of this research is therefore to investigate adverse vaccination effects in adults with a history of Ménière’s disease. Specifically, the incidence of adverse effects, the factors associated with those reporting adverse effects and the relationship between the reporting of audiovestibular and other adverse effects. METHODS : A mixed-methods exploratory cross-sectional survey study design was used. Data were collected from 333 members of the Finnish Ménière Association. The survey was designed to obtain demographic information that may be associated with having adverse effects or not, vaccination-specific information and adverse vaccination effects. Both health and audiovestibular adverse events were identified. Data analysis included comparing those reporting and not reporting adverse vaccination effects. RESULTS : The mean age was 63 years with 81% being female. Of the 327 respondents who had one of the COVID-19 vaccinations (Comirnatry/ Pfizer, Astra Zeneca, or Moderna), 203 (62%) reported no adverse effects. The type of or number of vaccinations were not related to the reporting of adverse effects. The most frequently reported adverse effects were injection site tenderness (38%), arm pain (21%), fever (15%) and headaches (15%). Post-vaccination tinnitus and vertigo (both 7%) were the most frequently reported audiovestibular-related symptoms, followed by aural fullness (6%) and hearing loss (4%). Those reporting previous pre-vaccination vertigo were more likely to have post-vaccination vertigo. The presence of post-vaccination tinnitus, hearing loss, and aural fullness, predicted the presence of post-vaccination vertigo. CONCLUSIONS : A small proportion of patients with a history of Ménière’s disease may experience adverse post-vaccination effects. Further research is required to explore whether adverse postvaccination audiovestibular effects are more prevalent in those with a history of otological disorders compared with the general population. en_US
dc.description.department Speech-Language Pathology and Audiology en_US
dc.description.librarian am2023 en_US
dc.description.uri http://f1000research.com en_US
dc.identifier.citation Beukes, E., Manchaiah. V., Pyykkö, N. and Pyykkö, I. Adverse COVID-19 vaccination effects in Finnish patients with Ménière’s disease: a cross-sectional study. F1000Research 2022, 11:893 https://DOI.org/10.12688/f1000research.113143.1. en_US
dc.identifier.issn 2046-1402
dc.identifier.other 10.12688/f1000research.113143.1
dc.identifier.uri http://hdl.handle.net/2263/91208
dc.language.iso en en_US
dc.publisher F1000 Research Ltd en_US
dc.rights © 2022 Beukes E et al. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License. en_US
dc.subject Meniere’s disease en_US
dc.subject Audiovestibular en_US
dc.subject Vertigo en_US
dc.subject Hearing loss en_US
dc.subject Tinnitus en_US
dc.subject COVID-19 pandemic en_US
dc.subject Coronavirus disease 2019 (COVID-19) en_US
dc.subject Vaccination en_US
dc.subject SDG-03: Good health and well-being en_US
dc.title Adverse COVID-19 vaccination effects in Finnish patients with Meniere's disease : a cross-sectional study en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record